Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT20029 tincture in adult Chinese men with androgenetic alopecia
CTR20230669Phase 2Completed
- Sponsor
- Kintor Pharmaceutical Limited
- Start
- Mar 2023
- Modality
- PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GT20029 in androgenetic alopecia (AGA), sponsored by Kintor Pharmaceutical Limited. Started Mar 2023; status: completed.
02
Drugs
GT20029
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on CTR20230669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230669.